Condition: Left-sided Pancreatic Cancer · Sponsor: Fudan University
This multicenter randomized controlled clinical trial proposed the criteria for selecting patients with early-stage left-sided pancreatic cancer and aimed to compare the perioperative and oncological outcomes of patients within the criteria who underwent laparoscopic radical antegrade modular pancreatosplenectomy versus laparoscopic distal pancreatosplenectomy.
This description comes directly from the study's public registry record.
Xianjun Yu, MD, PhD · +86-13801669875 · yuxianjun@fudanpci.org
Zheng Li, MD · +86-18521097686 · lizheng@fudanpci.org
Always discuss trial participation with your own doctor first.
| Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05939063